NIH-funded research P30 center grant

A core facility for advanced bioinformatics analysis and support

Official title: Bioinformatics and Pathways Core

Funded at Oklahoma Medical Research Foundation · NIH-10873723 · Data updated 2026-11-12

This study is all about helping researchers analyze complex biological data to better understand diseases, which can lead to better treatments for patients like you.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation
NIH-funded
Lab location1 site (Oklahoma City, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$485,030
NIH project number5P30GM149376-02
Project IDNIH-10873723 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with conditions that are being studied through high-throughput genomic analyses.

Less likely to help

Patients with conditions that are not being addressed by the specific bioinformatics analyses conducted at the BPC may not receive direct benefits.

What this research studies

The Bioinformatics and Pathways Core (BPC) provides essential support for researchers conducting high-throughput experiments, such as RNA-seq and ChIP-seq, by offering bioinformatics analysis and statistical guidance. Patients can benefit from this research as it enhances the understanding of biological data, leading to improved disease insights and treatment strategies. The BPC employs experienced bioinformaticians and statisticians to assist in study design and data interpretation, ensuring that research is both rigorous and relevant to patient care.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments and personalized medicine approaches for various diseases.

How similar studies have gone: Previous research utilizing bioinformatics approaches has shown significant success in enhancing our understanding of complex diseases and improving treatment outcomes.

Where this research is happening

  • Oklahoma Medical Research Foundation
    Oklahoma City, United States
    Active

Researchers

  • Principal investigator: Wren, Jonathan Daniel — Oklahoma Medical Research Foundation
  • Study coordinator: Wren, Jonathan Daniel

Related research

Other NIH-funded projects on the same topics.

  • Understanding how DIS3L2 helps keep RNA in check to help lupus patients

    A physician-scientist team is studying how a watchdog molecule for RNA (DIS3L2) may drive lupus-related immune problems, with the goal of uncovering new paths to treatment.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11630879

  • Stem cell mRNA marks and fat-infiltrated aging muscles

    Researchers are studying how aging changes muscle at the cellular level, including fat and fibrous tissue buildup, to help keep older adults stronger and more mobile.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11593119

  • Tissue research hub for autoimmune diseases to speed up new treatments

    A national program is building a centralized tissue core to study autoimmune diseases like lupus, rheumatoid arthritis, Sjögren’s, and psoriatic conditions using advanced single-cell and spatial analysis.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11590648

  • Roles of mitochondrial transporters SLC25A22 and SLC25A46 in brain health

    This grant studies how two mitochondrial transporters, SLC25A22 and SLC25A46, affect brain metabolism and neurological disorders using fruit-fly models to uncover disease mechanisms.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11515601

  • Colon mucus sugars and how they help keep gut bacteria and the colon healthy

    Researchers are looking at how sugar-coated mucus made by cells in the front part of the colon helps keep gut bacteria balanced and may protect people with ulcerative colitis or pouch inflammation.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11401680

  • Oxidized lipids driving aging-related muscle loss

    This project explores how certain lipid molecules that are damaged or modified over time contribute to muscle weakness and loss in older adults, with the goal of identifying new ways to prevent sarcopenia.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11396249

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.